Literature DB >> 7260410

Diurnal variations of tumor growth and its influence on cytostatic treatment.

M Flentje, G Akokan, D Reinecke, H O Klein.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7260410     DOI: 10.1007/BF00320465

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


× No keyword cloud information.
  7 in total

1.  Investigations on pharmacologic induction of partial synchronization of tumor cell proliferation: its relevance for cytostatic therapy.

Authors:  H O Klein; D Adler; M Doering; P J Klein; K J Lennartz
Journal:  Cancer Treat Rep       Date:  1976-12

2.  Survival and cure of leukemic mice after circadian optimization of treatment with cyclophosphamide and 1-beta-D-arabinofuranosylcytosine.

Authors:  L E Scheving; E R Burns; J E Pauly; F Halberg; E Haus
Journal:  Cancer Res       Date:  1977-10       Impact factor: 12.701

3.  Circadian rhythms in DNA synthesis and mitosis in normal mice and mice bearing the Lewis lung carcinoma.

Authors:  E R Burns; L E Scheving; T H Tsai
Journal:  Eur J Cancer       Date:  1979-02       Impact factor: 9.162

4.  Cell population kinetics of transplanted and metastatic Lewis lung carcinoma.

Authors:  L Simpson-Herren; A H Sanford; J P Holmquist
Journal:  Cell Tissue Kinet       Date:  1974-07

5.  Biologic characterization of the subcutaneously implanted Lewis lung tumor.

Authors:  J G Mayo
Journal:  Cancer Chemother Rep 2       Date:  1972-11

6.  Evidence of a G1 regulation of circadian proliferation in mouse methylcholanthrene-induced sarcomas.

Authors:  C Focan; H Barbason; E H Betz
Journal:  Eur J Cancer       Date:  1979-11       Impact factor: 9.162

7.  Chronochemotherapy of L1210 leukemic mice with cytosine arabinoside or cyclophosphamide.

Authors:  W C Rose; M W Trader; W R Laster; F M Schabel
Journal:  Cancer Treat Rep       Date:  1978-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.